Individual Projects

Evaluation of an antibody detecting point-of-care test for the diagnosis of Taenia solium taeniosis and (neuro)cysticercosis in communities and primary care settings of highly endemic, resource-poor areas in Tanzania and Zambia, including training of - an

Reference number: 01KA1617
Funding amount: 967.057 EUR
Funding Period: 2016 - 2020
Project leader: PD Dr. Dr. Andrea Sylvia Winkler
Address: Klinikum rechts der Isar der Technischen Universität München, Neurochirurgische Klinik und Poliklinik
Ismaninger Str. 22
81675 München

The main objective of this study is to contribute to the implementation of a rapid, cheap and simple POC-test for the detection of T. solium taeniosis and (neuro)cysticercosis in two resource-poor, highly endemic areas in sub- Saharan Africa. The proposed project will therefore field validate the POC-test, which simultaneously detects T. solium taeniosis and (neuro)cysticercosis, in Tanzania and Zambia, both at the community and primary health facility levels. The project also aims to improve the T. solium disease recognition, diagnostic and clinical case management capacities of these countries as well as their capacity to conduct diagnostic and clinical studies. WHO has identified the development of POC-tests for T. solium TSCT/NCC as a top priority and confirms its endorsement and implementation if successfully validated. Commercialization of the test will be facilitated once successfully validated.